Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

NCT05065177 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1140
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sinovac Research and Development Co., Ltd.